Suprabhat Mukherjee (S Mukherjee)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

Future virology

Antibodies (Basel, Switzerland)

Journal of medical virology

Vaccines

Kazi Nazrul University

Visva-Bharati (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kazi Nazrul University Nov 22 2018

India

Assistant Professor :: Department of Animal Science

Education History

Visva-Bharati Jan 07 2012 - Dec 05 2016

India

PHD :: Zoology

University of Burdwan Aug 01 2007 - Sep 09 2009

India

MSC

Publications

Ankita Chakraborty, Advaitha Midde, Pritha Chakraborty, Sourin Adhikary, Simran Kumar, Navpreet Arri, Nabarun Chandra Das, Parth Sarthi Sen Gupta, Aditi Banerjee, Suprabhat Mukherjee
Revisiting Luteolin Against the Mediators of Human Metastatic Colorectal Carcinoma: A Biomolecular Approach. Journal of cellular biochemistry (2024)
Ankita Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
Helminth-derived biomolecules as potential therapeutics against ulcerative colitis. Immunotherapy (2024)
Nabarun Chandra Das, Pritha Chakraborty, Samapika Nandy, Abhijit Dey, Tadesse Asmamaw Dejenie, Suprabhat Mukherjee
Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings. Journal of cellular and molecular medicine (2023)
Ankita Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
Immunoinformatics Approaches in Designing Vaccines Against COVID-19. Methods in molecular biology (Clifton, N.J.) 2673 (2023)
Somrita Padma, Ritwik Patra, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach. Vaccines 11 (3) (2023)
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes. Future virology (2023)
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation. Antibodies (Basel, Switzerland) 12 (1) (2023)
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation. Antibodies (Basel, Switzerland) 12 (1) (2023)
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation. Antibodies (Basel, Switzerland) 12 (1) (2023)
Somrita Padma, Ritwik Patra, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Malay Kumar Rana, Suprabhat Mukherjee
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach. Vaccines 11 (3) (2023)
Ritwik Patra, Amit Kumar Dey, Suprabhat Mukherjee
Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. PloS one 18 (8) (2023)
Bhabani Shankar Das, Nabarun Chandra Das, Shasanka Sekhar Swain, Suprabhat Mukherjee, Debapriya Bhattacharya
Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study. Future virology (2022)
Suprabhat Mukherjee
Toll-like receptor 4 in COVID-19: friend or foe? Future virology (2022)
Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective. Advances in experimental medicine and biology 1352 (2022)
Nabarun Chandra Das, Parth Sarthi Sen Gupta, Satyaranjan Biswal, Ritwik Patra, Malay Kumar Rana, Suprabhat Mukherjee
In-silico evidences on filarial cystatin as a putative ligand of human TLR4. Journal of biomolecular structure & dynamics (2021)
Abhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, Suprabhat Mukherjee
In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans. Journal of medical virology 93 (4) (2021)
Ritwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Targeting human TLRs to combat COVID-19: A solution? Journal of medical virology 93 (2) (2020)
Abhigyan Choudhury, Suprabhat Mukherjee
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. Journal of medical virology 92 (10) (2020)
Suprabhat Mukherjee, Anupama Karnam, Mrinmoy Das, Santi P Sinha Babu, Jagadeesh Bayry
Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4. Communications biology 2 (2019)
Indranil Chakraborty, Urmila Saha, Dipika Mandal, Suprabhat Mukherjee, Nikhilesh Joardar, Santi P Sinha Babu, Gopinatha Suresh Kumar, Kalyan Mandal
Effect of bovine serum albumin on tartrate-modified manganese ferrite nano hollow spheres: spectroscopic and toxicity study. Physical chemistry chemical physics : PCCP 21 (20) (2019)
Suprabhat Mukherjee, Nikhilesh Joardar, Santi P Sinha Babu
Exploring the homolog of a novel proinflammatory microfilarial sheath protein (MfP) of Wuchereria bancrofti in the adult-stage bovine filarial parasite Setaria cervi. Journal of helminthology 94 (2018)

Suprabhat Mukherjee.css-eqlu8i{font-size:small;padding-left:4px;} (S Mukherjee)

Publication Activity (10 Years)

Top Topics

Top Venues

Suprabhat Mukherjee (S Mukherjee)